US 12,430,019 B2
Systems and methods incorporating a light therapy user interface for optical modulation
Joshua Dale Howard, Sacramento, CA (US); Michael A. Moffitt, Solon, OH (US); and Changfang Zhu, Valencia, CA (US)
Assigned to Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed by Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed on Dec. 27, 2023, as Appl. No. 18/397,740.
Claims priority of provisional application 63/437,050, filed on Jan. 4, 2023.
Prior Publication US 2024/0220094 A1, Jul. 4, 2024
Int. Cl. G06F 3/048 (2013.01); G06F 3/04847 (2022.01); A61N 5/06 (2006.01)
CPC G06F 3/04847 (2013.01) [A61N 5/0601 (2013.01)] 19 Claims
OG exemplary drawing
 
1. An optical modulation system, comprising:
a display;
a memory comprising instructions;
a processor coupled to the display and the memory and configured to execute the instructions, wherein the instructions comprise
presenting, on the display, a user interface comprising a plurality of user-selectable controls to select or adjust values for each of a plurality of modulation parameters;
receiving a target;
receiving or determining a location of an optical modulation lead relative to the target;
receiving a selection of the value for each of the modulation parameters;
presenting, on the display, a representation of the optical modulation lead and a representation of the target relative to the location of the optical modulation lead;
estimating a modulation dosage or irradiance at the target based on, at least, the target, the location of the optical modulation lead, the values of the modulation parameters, and estimated light attenuation by tissue between the optical modulation lead and the target; and
presenting, on the display, a value of the estimated modulation dosage or irradiance at the target.